<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00332371</url>
  </required_header>
  <id_info>
    <org_study_id>4817</org_study_id>
    <secondary_id>ISRCTN24534559</secondary_id>
    <nct_id>NCT00332371</nct_id>
  </id_info>
  <brief_title>COMPACT - COMbining Plasma-filtration and Adsorption Clinical Trial</brief_title>
  <official_title>COMPACT (COMbining Plasma-filtration and Adsorption Clinical Trial): Efficacy and Safety of CPFA (Coupled Plasma Filtration Adsorption) for Septic Shock in the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BELLCO S.r.l., Mirandola (MO), ITALY</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to clarify whether the application of CPFA (coupled plasma-filtration
      adsorption) in addition to the current clinical practice is able to reduce mortality and
      prevent organ failures in septic shock patients in intensive care unit (ICU).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Septic shock is a life-threatening clinical condition characterized by cardiovascular failure
      as a consequence of infection. Septic shock frequently causes multi-organ failure in the ICU.
      For this reason the extracorporeal therapies for the treatment of renal failure have become
      widespread in the ICU and, at the same time, new extracorporeal depurative techniques have
      been developed for the removal of inflammatory mediators. One of these techniques is CPFA
      (coupled plasma-filtration adsorption) that uses a sorbent once the separation between plasma
      and blood has been obtained with a plasma filter. The study objective is to clarify whether
      the application of CPFA in addition to the current clinical practice is able to reduce
      mortality and prevent organ failures in septic shock patients in intensive care unit.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was prematurely interrupted for futility.
  </why_stopped>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital mortality (for patients discharged to other hospital, it will be intended as mortality at the discharge from the latest hospital in which the patients stayed)</measure>
    <time_frame>At the discharge from the latest hospital</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality within 90 days from randomization</measure>
    <time_frame>90 days from randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New organ failures (assessed through SOFA score)</measure>
    <time_frame>Within ICU stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days not spent in the ICU during the first 30 days from randomization</measure>
    <time_frame>30 days from randomization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Shock, Septic</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPFA (Coupled Plasma Filtration Adsorption)</intervention_name>
    <description>CPFA is a specific method for the treatment of sepsis.
It consists of:
a plasma-filter (polyethersulfone 0.45 m2 with a cutoff of approx 800 kDa)
a hemofilter (polyethersulfone 1,4 m2)
a cartridge (contains approximately 140 ml of hydrophobic styrenic resin)
The kit is lodged in the Bellco &quot;Lynda&quot; machine (Bellco Mirandola, Italy). The treatment consists of the separation of plasma from the whole blood with adsorption of the inflammatory mediators and cytokines from the plasma, and a subsequent purification step by way of a hemofilter.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Coupled Plasma Filtration Adsorption</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients admitted to the ICU in septic shock

          -  All patients that develop septic shock while in the ICU

        Exclusion Criteria:

          -  Age less than 18 years

          -  Pregnancy

          -  Cardiopulmonary resuscitation

          -  Cerebral coma

          -  Metastatic cancer

          -  Presence of relative or absolute contraindications to CPFA

          -  Estimated life expectancy less than 2 weeks

          -  Already included in the study

          -  Admission from an other ICU where the patient remained for more than 24 hours

          -  Absence of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergio Livigni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Giovanni Bosco, Torino, ITALY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale SS. Antonio e Biagio e C. Arrigo</name>
      <address>
        <city>Alessandria</city>
        <state>AL</state>
        <zip>15100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale della Valle d'Aosta, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Aosta</city>
        <state>AO</state>
        <zip>11100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti, I Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Bergamo</city>
        <state>BG</state>
        <zip>24128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Policlinico San Pietro, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Ponte San Pietro</city>
        <state>BG</state>
        <zip>24036</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Policlinico San Marco, Terapia Intensiva</name>
      <address>
        <city>Zingonia</city>
        <state>BG</state>
        <zip>24040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Spedali Civili, II Servizio di Anestesia e Rianimazione</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Vittorio Emanuele, II Servizio di Anestesia e Rianimazione</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <zip>95100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Morgagni-Pierantoni, U.O. Anestesia e Rianimazione</name>
      <address>
        <city>Forl√¨</city>
        <state>FC</state>
        <zip>47100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Careggi - Villa Monna Tessa, TI Polifunzionale e Post-trapianto</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Giovanni di Dio ASL 10, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50143</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile</name>
      <address>
        <city>Imperia</city>
        <state>IM</state>
        <zip>18100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Sanremo</city>
        <state>IM</state>
        <zip>18038</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale A. Manzoni, U.O. Anestesia e Rianimazione 1</name>
      <address>
        <city>Lecco</city>
        <state>LC</state>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Madonna delle Grazie, U.O. Anestesia e Rianimazione</name>
      <address>
        <city>Matera</city>
        <state>MT</state>
        <zip>75100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di S. Chiara, VI U.O. di Anestesia, Rianimazione e Pronto Soccorso</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <zip>56100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>European Hospital</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Camillo Forlanini</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00152</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Regione Piemonte ASL 9, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Ivrea</city>
        <state>TO</state>
        <zip>10015</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Bosco, Servizio Anestesia e Rianimazione B-DEA</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10148</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.giviti.marionegri.it</url>
    <description>GiViTI official web site</description>
  </link>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2006</study_first_submitted>
  <study_first_submitted_qc>May 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2006</study_first_posted>
  <last_update_submitted>July 5, 2012</last_update_submitted>
  <last_update_submitted_qc>July 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive Care</keyword>
  <keyword>Shock, Septic</keyword>
  <keyword>Adsorption</keyword>
  <keyword>Sorption Detoxification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

